MetLife Investment Management’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-31,642
| Closed | -$98.1K | – | 2911 |
|
|
2024
Q2 | $98.1K | Buy |
31,642
+5,751
| +22% | +$17.8K | ﹤0.01% | 2614 |
|
|
2024
Q1 | $135K | Buy |
+25,891
| New | +$135K | ﹤0.01% | 2393 |
|
|
2023
Q4 | – | Sell |
-25,148
| Closed | -$64.1K | – | 2862 |
|
|
2023
Q3 | $64.1K | Hold |
25,148
| – | – | ﹤0.01% | 2790 |
|
|
2023
Q2 | $148K | Buy |
+25,148
| New | +$148K | ﹤0.01% | 2449 |
|
|
2022
Q2 | – | Sell |
-18,722
| Closed | -$221K | – | 2906 |
|
|
2022
Q1 | $221K | Buy |
18,722
+12,865
| +220% | +$152K | ﹤0.01% | 2297 |
|
|
2021
Q4 | $111K | Hold |
5,857
| – | – | ﹤0.01% | 2373 |
|
|
2021
Q3 | $121K | Buy |
+5,857
| New | +$121K | ﹤0.01% | 2354 |
|